PLEURAL MESOTHELIOMA
Clinical trials for PLEURAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PLEURAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested to boost cancer immunotherapy
Disease control Recruiting nowThis study is testing a new oral medication called Alintegimod, given alongside the immunotherapy drugs ipilimumab and nivolumab. It aims to see if this combination is safe and can help control advanced cancers that have spread or returned after other treatments. The study will e…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: 7 Hills Pharma, LLC • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New drug combo targets genetic weakness in tough cancers
Disease control Recruiting nowThis early-stage study is testing a new drug, IDE892, both alone and in combination with another drug called IDE397. It is for adults with advanced solid tumors that have a specific genetic change called MTAP deletion and have stopped responding to standard treatments. The main g…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Italian researchers develop advanced cancer testing system
Diagnosis Recruiting nowThis study is testing a new diagnostic platform called IT-TCP that analyzes tumor samples from patients with high-risk cancers. Researchers will collect samples from 300 patients with various cancers including leukemia, pancreatic cancer, and melanoma to see if this detailed anal…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC